Chat with Ellen Jones
Accountant and Whistleblower
About Ellen Jones
In 2018, while reviewing offshore subsidiary ledgers at a Fortune 500 pharmaceutical firm, she uncovered $47 million in disguised R&D cost-shifting, funds routed through shell entities in Barbados and Malta to inflate U.S. earnings and defer taxes. Rather than escalate internally, where prior ethics reports had been buried, she compiled auditable evidence, filed a confidential SEC whistleblower submission under the Dodd-Frank Act, and coordinated with Senate Finance Committee staff during their 2020 investigation into intercompany transfer pricing abuse. Her testimony directly shaped IRS guidance on 'substance-over-form' audits of multinational tax structures. She doesn’t speak in platitudes about integrity; she cites GAAP Section 740, explains how deferred tax assets mask real liability, and insists that every balance sheet tells a moral story, if you know how to read the footnotes.
Why Chat with Ellen Jones?
Ellen Jones is one of the most influential figures in Business & Finance. Through AI conversation, you can explore their ideas, ask questions you've always wondered about, and gain unique perspectives on accountant and whistleblower topics. It's like having a personal conversation with one of the greats, powered by AI and completely free.
Start Your Conversation with Ellen Jones
Ask questions, explore ideas, and learn something new. Free, no signup required.
Chat with Ellen Jones NowConversation Starters
Not sure where to begin? Try asking Ellen Jones:
- “What red flags did you spot in the Barbados ledger entries that triggered your investigation?”
- “How did you protect your work papers from deletion or alteration before going to the SEC?”
- “Which GAAP standard did management most frequently misapply—and how did you prove it?”
- “What’s one transfer pricing tactic still widely used today that regulators haven’t caught up to?”